Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents

View ORCID ProfileAli Zhang, View ORCID ProfileJessica A. Breznik, Rumi Clare, View ORCID ProfileIshac Nazy, View ORCID ProfileMatthew S. Miller, View ORCID ProfileDawn M. E. Bowdish, View ORCID ProfileAndrew P. Costa
doi: https://doi.org/10.1101/2021.12.17.21267996
Ali Zhang
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
4Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ali Zhang
Jessica A. Breznik
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jessica A. Breznik
Rumi Clare
3Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishac Nazy
3Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
5McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ishac Nazy
Matthew S. Miller
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
4Department of Biochemistry & Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew S. Miller
Dawn M. E. Bowdish
1McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada
2Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada
3Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
6Firestone Institute of Respiratory Health, St Joseph’s Healthcare, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Dawn M. E. Bowdish
  • For correspondence: bowdish@mcmaster.ca acosta@mcmaster.ca
Andrew P. Costa
3Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada
7Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
8Centre for Integrated Care, St. Joseph’s Health System, Hamilton, Ontario, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew P. Costa
  • For correspondence: bowdish@mcmaster.ca acosta@mcmaster.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

A comparison of SARS-CoV-2 wild-type and the beta variant virus neutralization capacity between 2 and 3 mRNA vaccine series in nursing home residents, and between nursing home and assisted living residents strongly supports 3rd dose vaccine recommendations, and equivalent polices for nursing homes and assisted living settings. Findings suggest that residents mount a robust humoral response to a 3rd mRNA vaccination, and have greater neuralization capacity compared to a 2 dose series.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was funded by a grant from Canadian COVID-19 Immunity Task Force and Public Health Agency of Canada.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All protocols were approved by the Hamilton Integrated Research Ethics Board, and informed consent was obtained (HiREB #13059).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding Sources: This work was funded by a grant from Canadian COVID-19 Immunity Task Force and Public Health Agency of Canada awarded to APC and DMEB. DMEB is the Canada Research Chair in Aging & Immunity. APC is the Schlegel Chair in Clinical Epidemiology and Aging. Funding support for this work was provided by grants from the Ontario Research Foundation, COVID-19 Rapid Research Fund, and by the Canadian COVID-19 Immunity Task Force awarded to IN. MSM is supported, in part, by an Ontario Early Researcher Award.

  • Additional Information: Data in this study were collected by the COVID-in-LTC Study Group. Members of the COVID-in-LTC Study Group include Jonathan L. Bramson, PhD; Eric D. Brown, PhD; Kevin Brown, PhD; David C. Bulir, MD, PhD; Judah A. Denburg, MD; George A. Heckman, MD, MSc; Michael P. Hillmer, PhD; John P. Hirdes, PhD; Aaron Jones, PhD; Mark Loeb, MD, MSc; Janet E. McElhaney, MD; Ishac Nazy, PhD; Nathan M. Stall, MD; Parminder Raina, PhD; Marek Smieja, MD, PhD; Kevin J. Stinson, PhD; Ahmad Von Schlegell; Arthur Sweetman, PhD; Chris Verschoor, PhD; Gerry Wright, PhD. The authors declare no conflicts of interest.

  • Conflict of Interest Disclosures: None reported. The authors have no financial relationship with any organization that may have an interest, and have no other relationships or activities that could appear to have influenced the submitted work.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 18, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
Ali Zhang, Jessica A. Breznik, Rumi Clare, Ishac Nazy, Matthew S. Miller, Dawn M. E. Bowdish, Andrew P. Costa
medRxiv 2021.12.17.21267996; doi: https://doi.org/10.1101/2021.12.17.21267996
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Antibody Responses to 3rd Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
Ali Zhang, Jessica A. Breznik, Rumi Clare, Ishac Nazy, Matthew S. Miller, Dawn M. E. Bowdish, Andrew P. Costa
medRxiv 2021.12.17.21267996; doi: https://doi.org/10.1101/2021.12.17.21267996

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (162)
  • Allergy and Immunology (416)
  • Anesthesia (91)
  • Cardiovascular Medicine (862)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (394)
  • Epidemiology (8570)
  • Forensic Medicine (4)
  • Gastroenterology (387)
  • Genetic and Genomic Medicine (1756)
  • Geriatric Medicine (167)
  • Health Economics (373)
  • Health Informatics (1249)
  • Health Policy (622)
  • Health Systems and Quality Improvement (468)
  • Hematology (196)
  • HIV/AIDS (378)
  • Infectious Diseases (except HIV/AIDS) (10316)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (212)
  • Neurology (1680)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (328)
  • Occupational and Environmental Health (451)
  • Oncology (930)
  • Ophthalmology (263)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (253)
  • Pediatrics (536)
  • Pharmacology and Therapeutics (254)
  • Primary Care Research (209)
  • Psychiatry and Clinical Psychology (1775)
  • Public and Global Health (3850)
  • Radiology and Imaging (624)
  • Rehabilitation Medicine and Physical Therapy (320)
  • Respiratory Medicine (521)
  • Rheumatology (208)
  • Sexual and Reproductive Health (168)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)